Dr. Bose discusses his perspective on quality-of-life preservation for his patients with myelofibrosis, including the ...

Anne P. O'Dea, MD, presents the case of a 49-year-old woman with HR+/HER2- metastatic breast cancer and offers initial ...

John M. Burke, MD, discusses results from a phase 2 study which evaluated brentuximab vedotin, nivolumab, doxorubicin, and ...

In an interview with Targeted Oncology, Ben Jones identified the key challenges community oncologists are facing due to ...

The FDA accepted the supplemental biologics license for dostarlimab plus standard-of-care chemotherapy for all patients with ...

Warren Fingrut, MD, discussed a study looking at HLA antibody burden among patients with blood cancers, particularly women ...

In the interview with Targeted Oncology, Sanjay K. Juneja, MD, 2024 Oncology Icons honoree, discusses the transformative ...

Ira Zackon, MD, discusses the background of a real-world study which sought to identify some of the racial and socioeconomic ...

Patients with Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer carcinoma in situ now have a new ...

Cohen, MD, associate professor of medicine at the Hospital of the University of Pennsylvania, discusses ongoing research ...

At a live virtual event, Leyla Shune, MD, discussed the emergence of talquetamab-tgvs for patients with relapsed/refractory ...

During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, ...